A-SEEDS, an innovative biotech company sprouted from Shinshu University, is dedicated to pioneering advanced treatments for life-threatening cancers. Harnessing the potential of non-viral genetic engineering, our cutting-edge immune cell therapy opens up new horizons of hope for patients seeking effective and transformative solutions.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 3-1-1, Asahi, #207 Center For Shinshu Medical Innovation Of Regional Technology (Csmit),japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.a-seeds.co.jp/
- Keywords
- Cell Therapy, CAR-T cells, Cancer treatment.
- HQ
- Matsumoto, Nagano
A-Seeds Co., Ltd. Questions
A-Seeds Co., Ltd.'s website is https://www.a-seeds.co.jp/
A-Seeds Co., Ltd.'s LinkedIn profile is https://jp.linkedin.com/company/a-seeds-co-ltd
A-Seeds Co., Ltd. has
5 employees.
View email and phone details for 5
employees at A-Seeds Co., Ltd..
A-Seeds Co., Ltd.'s industry is
Biotechnology Research
A-Seeds Co., Ltd.'s top competitors are
Caelum Diagnostic Solutions,
United Immunity, Co., Ltd.,
Rakuten Medical,
An Venture Partners,
Viridian Seeds,
Typewriter Therapeutics, Inc.,
Arch Venture Partners,
Mpm Bioimpact,
Orphanpacific Inc.,
Novo Ventures.
A-Seeds Co., Ltd.'s categories are Biotechnology Research
A-Seeds Co., Ltd.'s founding year is 2020
